TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further ...

Treatment options for end-stage COPD are similar to those used in earlier stages of the condition. These may include: medications pulmonary rehabilitation oxygen therapy The use of any of these ...

Scientists at Newcastle University in the UK have developed a groundbreaking scanning technique that shows how lungs work ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

Idiopathic Pulmonary Fibrosis, the condition that led to Zakir Hussain's death, is a debilitating disease with lung ...

While millions of people live with chronic obstructive pulmonary disease (COPD), many don’t realize they have it until it ...

New imaging techniques reveal real-time lung function improvements, offering a breakthrough in diagnosing and treating ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

A novel way of scanning lungs can demonstrate the impact of treatment on lung function in real-time, allowing experts to ...